Aurora sponsors cancer-pain study featuring MedReleaf capsules. Continue reading Aurora Cannabis sponsors cancer-pain study directed by internationally acclaimed oncologist.
CannTrust investing approx. CAD $6 million for 20% stake in Australian company Cannatrek. Continue reading CannTrust stakes claim in Australia
Columbia University researchers hoping high-CBD, low-THC strain of cannabis will be well tolerated in patients with aggressive form of brain cancer, #glioblastoma and decrease radiation-induced toxicities and nausea and other symptoms. Continue reading Reducing toxic effects of chemo-radiation in brain-cancer patients
Researchers have discovered that cannabis is frequently used to alleviate diarrhea, abdominal pain, and loss of appetite caused by inflammatory bowel disease.
Several clinical trials are planned or underway to assess the effectiveness of THC and CBD in treating these conditions, such a Crohn’s and colitis. Continue reading Can THC treat inflammatory bowel disease?
GW Pharmaceuticals is conducting a clinical trial on the effectiveness of its #CBD drug in treating tremors in #Parkinson’s Disease.
The company said it expects to complete the study in June 2019. Continue reading GW Pharma clinical trial for Parkinsons
Nothing short of a total mind shift in how we treat addiction will solve the current opioid epidemic. Medical cannabinoids must be part of the solution. Continue reading CBD reduces heroin craving a week after the last dose, says New York psychiatry prof & addictions specialist
Children with a severe form of #epilepsy experienced fewer seizures and a better quality of life, according to the first study of its kind.
@Tilray CBD oil was used in the phase 2 clinical trial. Continue reading Tilray’s CBD/THC mixture found safe kids with drug-resistant epilepsy
Clinical trials will test CBD as treatment for psychosis and schizophrenia.
Renowned expert from Mount Sinai School of Medicine said findings are consistent with other clinical investigations affirming CBD’s antipsychotic properties.
Continue reading UPDATED: Clinical trials will test CBD as treatment for schizophrenia
New clinical study today announced by Phoenix-based biomed company will explore CBD oral solution on symptoms of early psychosis plus the drive behind excessive eating behaviour that accompanies antipsychotic medication use. Continue reading Clinical study: CBD for psychosis & excessive eating caused by antipsychotics
With $150 million BMO financing for growth capital in place @Aurora_MMJ further positions itself as global enterprise with strong portfolio of diversified assets.
Deal includes $50M LOC & $250M opinion to upsize Aurora Sky #cannabis Continue reading Aurora closes $150M debt deal with BMO